Abstract
Objective
The study aimed to evaluate and compare the efficacy and safety of dihydroartemisinin-piperaquine phosphate (Artekin) and artemisinin-piperaquine (Artequick) in the treatment of uncomplicated falciparum malaria.
Methods
A total of 103 uncomplicated falciparum malaria patients were enrolled and randomly assigned to two groups: 52 cases in the Artequick group, and 51 cases in the Artekin group. The patients in the Artequick group were administered with Artequick, twice in 24 h, whereas the patients in the Artekin group were given Artekin 4 times in 2 days. The mean parasite clearance time, mean fever clearance time, 28-day cure rate and parasite recrudescence rates of the two groups were then compared.
Results
The mean parasite clearance time and the mean fever clearance time were 43.2±13.9 h and 24.7±9.9 h, in the Artequick group, and 36.5±17.1 h and 22.7±11.2 h, in the Artekin group. In both groups the 28-day cure rate was 100%, and the parasite recrudescence rate was 0.
Conclusion
Both medicines had high cure rates, low recrudescence rates, and no serious adverse reactions. The administration of Artequick, however, was more convenient and lower incidence of gastrointestinal side effects than that of Artekin, so as to increase the efficacy in the malaria population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jose A. Najera, Joahim Hempel. The burden of malaria, CTD/MAL/96.10. http://www.rbm.who.int/cmc_upload/0/000/009/511/burden_najera.pdf
WHO. World malaria report. Geneva: World Health Organization; 2005. http://www.unicef.org/media/files/MalariaFactSheet.pdf
WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2006. http://whqlibdoc.who.int/publications/2006/9241546948_eng.pdf
WHO. Assessment and monitoring of Antimalarial drug efficacy for the treatment of uncompcicated falciparum malaria. Geneva: World Health Organization; 2003. http://www.who.int/malaria/docs/ProtocolWHO.pdf
Song JP, Socheat D, Seila S, Tharith T, Satim S, Yuthease S, et al. Clinical observation of dihydroartemisinin-piperaquine phosphate in treatment of uncomplicated falciparum malaria. Natl Med J Chin (Chin) 2003;83: 1099–1100.
Karema C, Fanello CI, van Overmeir C, van Geertruyden JP, van Doren W, Ngamije D, et al. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg 2006;100:1105–1111.
Tangpukdee N, Krudsood S, Thanachartwet W, Chalermrut K, Pengruksa C, Srivilairit S, et al. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 2005;36:1085–1091.
Song JP, Fu LC, Tan B, Li GQ. Randomized controlled trial of dihydroartemisinin piperaquine phosphate tablets in treatment of uncomplicated falciparum malaria. Chin J New Drugs (Chin) 2004;11: 783–785.
Chen L, Qu FY, Zhou YC. Field observation on the antimalarial piperaquine. Chin J Med (Chin) 1982; 95:281–286.
Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, et al. Dihydroartemisinin-piperaquine against multidrug-resistant plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 2004;363:18–22.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by Science and Technology Research Projects of Guangdong Province (No. 2005A30101009)
Rights and permissions
About this article
Cite this article
Trung, T.N., Tan, B., Van Phuc, D. et al. A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria. Chin. J. Integr. Med. 15, 189–192 (2009). https://doi.org/10.1007/s11655-009-0189-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-009-0189-6